General AML,   IDH1/2,  FLT3

Assist. Prof. Amir T. Fathi | ASH 2016 | Use of targeted therapies (FLT3 and IDH 1/2 inhibitors) in various settings

L:

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF